Featured Research

from universities, journals, and other organizations

Moderate fish consumption may lower risk in patients with a history of heart failure

Date:
December 21, 2009
Source:
Institute of Food Technologists (IFT)
Summary:
Including fish in a balanced diet has long been associated with the prevention of heart disease, and scientists now believe that it can help preserve heart function in patients who have experienced heart failure. A new study reports that moderate fish consumption can help reduce the risk of left ventricular systolic dysfunction (LVSD) in post acute coronary syndrome (ACS) patients.

Including fish in a balanced diet has long been associated with the prevention of heart disease, and scientists now believe that it can help preserve heart function in patients who have experienced heart failure. A new study in the Journal of Food Science reports that moderate fish consumption can help reduce the risk of left ventricular systolic dysfunction (LVSD) in post acute coronary syndrome (ACS) patients.

Researchers from the University of Athens in Greece focused on demographical, nutritional, lifestyle, and medical factors combined with the risk of developing left ventricular dysfunction after nonfatal heart failure. The study included nearly one thousand patients who were hospitalized after ACS. At the study's conclusion, researchers noted that consuming fish one to two times per week was independently associated with a considerable reduction of the odds of developing LVSD. However, a higher consumption of fish did not result in further protection from the occurrence of LVSD.

Lead researcher Dr. D. Panagiotakos states, "More research is necessary in this area, including the determination of the type of fish consumed as well as the type of the cooking method (boiling, baking, frying." The authors cite a study that determined consumption of a wide variety of fish is best for minimizing mercury exposure and increasing omega-3 fatty acid intake.


Story Source:

The above story is based on materials provided by Institute of Food Technologists (IFT). Note: Materials may be edited for content and length.


Cite This Page:

Institute of Food Technologists (IFT). "Moderate fish consumption may lower risk in patients with a history of heart failure." ScienceDaily. ScienceDaily, 21 December 2009. <www.sciencedaily.com/releases/2009/12/091218125944.htm>.
Institute of Food Technologists (IFT). (2009, December 21). Moderate fish consumption may lower risk in patients with a history of heart failure. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2009/12/091218125944.htm
Institute of Food Technologists (IFT). "Moderate fish consumption may lower risk in patients with a history of heart failure." ScienceDaily. www.sciencedaily.com/releases/2009/12/091218125944.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins